Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Iron deficiency in infants and children <12 years: Treatment

Jacquelyn M Powers, MD, MS
Donald H Mahoney, Jr, MD
Section Editors
Kathleen J Motil, MD, PhD
Jan E Drutz, MD
Deputy Editor
Alison G Hoppin, MD


Iron deficiency is the most common nutritional deficiency in children. The World Health Organization (WHO) estimates that anemia affects one-quarter of the world's population and is concentrated within preschool-aged children and women; anemia in the majority of individuals is due to iron deficiency. Iron deficiency is a particularly challenging problem for resource-limited nations in Asia and Africa [1,2]. In the United States and other resource-rich countries, rates of iron deficiency are substantially lower and are gradually improving. Nonetheless, iron deficiency remains common and has important consequences for health and neurodevelopment. (See "Iron deficiency in infants and children <12 years: Screening, prevention, clinical manifestations, and diagnosis", section on 'Prevalence'.)

The treatment of iron deficiency in infants and young children will be reviewed here. Related material can be found in the following topic reviews:

(See "Iron deficiency in infants and children <12 years: Screening, prevention, clinical manifestations, and diagnosis".)

(See "Iron requirements and iron deficiency in adolescents".)

(See "Approach to the child with anemia".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Sep 2017. | This topic last updated: Sep 27, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull 2003; 24:S99.
  2. DeBenoist, B, McLean, E, Egli, I, et al. Worldwide prevalence of anemia 1993-2005: WHO global database on anemia. World Health Organization, Geneva, 2008. Available at: http://www.who.int/vmnis/anaemia/prevalence/en/ (Accessed on July 11, 2017).
  3. Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010; 126:1040.
  4. Abrams SA, O'Brien KO, Wen J, et al. Absorption by 1-year-old children of an iron supplement given with cow's milk or juice. Pediatr Res 1996; 39:171.
  5. Powers JM, Buchanan GR, Adix L, et al. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial. JAMA 2017; 317:2297.
  6. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005; 118:1142.
  7. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015; 126:1981.
  8. Iron-fortified formulas and gastrointestinal symptoms in infants: a controlled study, With the cooperation of The Syracuse Consortium for Pediatric Clinical Studies. Pediatrics 1980; 66:168.
  9. Nelson SE, Ziegler EE, Copeland AM, et al. Lack of adverse reactions to iron-fortified formula. Pediatrics 1988; 81:360.
  10. Ziegler EE, Nelson SE, Jeter JM. Iron supplementation of breastfed infants from an early age. Am J Clin Nutr 2009; 89:525.
  11. Nagpal J, Sachdev HP, Singh T, Mallika V. A randomized placebo-controlled trial of iron supplementation in breastfed young infants initiated on complementary feeding: effect on haematological status. J Health Popul Nutr 2004; 22:203.
  12. Zavaleta N, Respicio G, Garcia T. Efficacy and acceptability of two iron supplementation schedules in adolescent school girls in Lima, Peru. J Nutr 2000; 130:462S.
  13. Reeves JD, Yip R. Lack of adverse side effects of oral ferrous sulfate therapy in 1-year-old infants. Pediatrics 1985; 75:352.
  14. Soh P, Ferguson EL, McKenzie JE, et al. Iron deficiency and risk factors for lower iron stores in 6-24-month-old New Zealanders. Eur J Clin Nutr 2004; 58:71.
  15. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1.
  16. Brotanek JM, Halterman JS, Auinger P, et al. Iron deficiency, prolonged bottle-feeding, and racial/ethnic disparities in young children. Arch Pediatr Adolesc Med 2005; 159:1038.
  17. Powers JM, Daniel CL, McCavit TL, Buchanan GR. Deficiencies in the Management of Iron Deficiency Anemia During Childhood. Pediatr Blood Cancer 2016; 63:743.
  18. Finberg KE. Iron-refractory iron deficiency anemia. Semin Hematol 2009; 46:378.
  19. DIAMOND LK, NAIMAN JL, ALLEN DM, OSKI FA. The treatment of iron-deficiency anemia--palatable but ineffective iron medication. Pediatrics 1963; 31:1041.
  20. McDonnell WM, Ryan JA, Seeger DM, Elta GH. Effect of iron on the guaiac reaction. Gastroenterology 1989; 96:74.
  21. Anderson GD, Yuellig TR, Krone RE Jr. An investigation into the effects of oral iron supplementation on in vivo Hemoccult stool testing. Am J Gastroenterol 1990; 85:558.
  22. Coles EF, Starnes EC. Use of HemoQuant assays to assess the effect of oral iron preparations on stool hemoccult tests. Am J Gastroenterol 1991; 86:1442.
  23. Mantadakis E. Advances in Pediatric Intravenous Iron Therapy. Pediatr Blood Cancer 2016; 63:11.
  24. Crary SE, Hall K, Buchanan GR. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer 2011; 56:615.
  25. Plummer ES, Crary SE, McCavit TL, Buchanan GR. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Pediatr Blood Cancer 2013; 60:1747.
  26. Powers JM, Shamoun M, McCavit TL, et al. Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron. J Pediatr 2017; 180:212.
  27. Laass MW, Straub S, Chainey S, et al. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol 2014; 14:184.